PFKFB2 has been shown to be upregulated as a consequence of the transcriptional changes orchestrated by the androgen receptor in prostate cancer cells, with possible control through the AR-CAMKII-AMPK signaling pathway [50]. This evidence concerns the gene PFKFB2 and prostate cancer.